CAMBRIDGE, Mass.--(BUSINESS WIRE)--Atlas Venture, a leading early stage venture capital firm investing in groundbreaking biotech innovation, today announced the closing of its twelfth fund, raising ...

New fund will invest growth capital in Atlas-backed biotech companies Atlas Venture, a leading early stage venture capital firm investing in groundbreaking biotech innovation, today announced the ...

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Atlas Venture, a leading early stage biotech venture capital firm, today announced that Andrea Armstrong has joined as chief talent officer. Andrea will lead the ...

Atlas Venture, a leading early stage venture capital firm investing in groundbreaking biotech innovation, today announced the closing of its fourteenth fund, raising $450 million in an oversubscribed ...

Biotech stocks overall may be down, but that hasn't stopped venture capital and creation firm Atlas Venture from raising $450 million for its latest fund. Biotech stocks overall may be down, but that ...

Atlas Venture said June 1 that Kevin Bitterman is joining the firm as a partner. Bitterman was previously a partner with Polaris Partners. CAMBRIDGE, Mass.–(BUSINESS WIRE)–Atlas Venture, a leading ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Atlas Venture, a leading early stage venture capital and venture creation firm investing in biotech innovation, today announced the closing of its second Opportunity ...

ST. LOUIS and CAMBRIDGE, Mass., April 14, 2011 /PRNewswire/ -- Monsanto Company (NYSE: MON) and Atlas Venture, an early-stage venture capital firm based in Cambridge, Mass., today announced an ...

A biotechnology venture capital firm is ringing in the new year with its latest fund, having raised a quarter of $1 billion. Cambridge, Massachusetts-based Atlas Venture said Wednesday that it closed ...

Atlas Venture has raised $250 million to invest in existing portfolio companies. The fund, the first of its kind operated by Atlas, will enable the VC shop to support its startups through series B and ...

One of the quirks about drug hunting is that finding new medicines doesn’t always mean uncovering something completely new. Sometimes it’s about revisiting previously hunted grounds and spotting ...

Atlas Venture, the Cambridge, Mass.-based early-stage, biotech-focused venture firm, has for the first time raised an opportunity fund designed to help it support its most promising, maturing ...